normalization of granulocyte counts was obtained with low-dose cytosine arabinoside ( ara-c ) in a patient with acute myelogenous leukemia ( aml , fab-m2 ) who had relapsed on maintenance therapy containing conventional doses of ara-c and was clinically resistant to high-dose ara-c treatment .
C0023467
aml
C1879321
fab-m2